###begin article-title 0
A Novel RNA Transcript with Antiapoptotic Function Is Silenced in Fragile X Syndrome
###end article-title 0
###begin p 1
Conceived and designed the experiments: CW AK MF. Performed the experiments: AK MF FM SB. Analyzed the data: CW AK MF FM SB. Contributed reagents/materials/analysis tools: CW. Wrote the paper: CW AK MF.
###end p 1
###begin p 2
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 531 535 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 607 612 607 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1.</italic>
###xml 648 652 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 716 720 716 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 733 737 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 831 835 831 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 869 873 869 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 890 900 890 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vice versa</italic>
###xml 918 922 918 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 965 969 965 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 980 984 980 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1028 1036 1028 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1058 1062 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1158 1162 1158 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1272 1276 1272 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1410 1414 1410 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 348 353 <span type="species:ncbi:9606">human</span>
###xml 767 775 <span type="species:ncbi:9606">patients</span>
###xml 1003 1008 <span type="species:ncbi:9606">human</span>
Several genome-wide transcriptomics efforts have shown that a large percentage of the mammalian genome is transcribed into RNAs, however, only a small percentage (1-2%) of these RNAs is translated into proteins. Currently there is an intense interest in characterizing the function of the different classes of noncoding RNAs and their relevance to human disease. Using genomic approaches we discovered FMR4, a primate-specific noncoding RNA transcript (2.4 kb) that resides upstream and likely shares a bidirectional promoter with FMR1. FMR4 is a product of RNA polymerase II and has a similar half-life to FMR1. The CGG expansion in the 5' UTR of FMR1 appears to affect transcription in both directions as we found FMR4, similar to FMR1, to be silenced in fragile X patients and up-regulated in premutation carriers. Knockdown of FMR4 by several siRNAs did not affect FMR1 expression, nor vice versa, suggesting that FMR4 is not a direct regulatory transcript for FMR1. However, FMR4 markedly affected human cell proliferation in vitro; siRNAs knockdown of FMR4 resulted in alterations in the cell cycle and increased apoptosis, while the overexpression of FMR4 caused an increase in cell proliferation. Collectively, our results demonstrate an antiapoptotic function of FMR4 and provide evidence that a well-studied genomic locus can show unexpected functional complexity. It cannot be excluded that altered FMR4 expression might contribute to aspects of the clinical presentation of fragile X syndrome and/or related disorders.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 118 121 118 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Carninci1">[1]</xref>
###xml 122 125 122 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Birney1">[3]</xref>
###xml 487 490 487 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Bartel1">[4]</xref>
###xml 517 520 517 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Fire1">[5]</xref>
###xml 559 562 559 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Carmell1">[6]</xref>
###xml 564 567 564 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Houwing1">[7]</xref>
###xml 659 662 659 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Katayama1">[8]</xref>
###xml 860 863 860 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Katayama1">[8]</xref>
###xml 1075 1078 1075 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Pang1">[9]</xref>
###xml 1080 1084 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Ponjavic1">[10]</xref>
###xml 1227 1230 1215 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Pang1">[9]</xref>
###xml 1232 1236 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Wahlestedt1">[11]</xref>
###xml 1392 1395 1380 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Pang1">[9]</xref>
###xml 1418 1424 1406 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in cis</italic>
###xml 1426 1429 1414 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g</italic>
###xml 1432 1436 1420 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XIST</italic>
###xml 1438 1442 1426 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Migeon1">[12]</xref>
###xml 1447 1455 1435 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 1463 1469 1451 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOTAIR</italic>
###xml 1471 1475 1459 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Rinn1">[13]</xref>
###xml 1747 1751 1735 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-He1">[14]</xref>
###xml 1753 1757 1741 1745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Ikeda1">[15]</xref>
###xml 1896 1900 1884 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Wahlestedt1">[11]</xref>
###xml 1902 1906 1890 1894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Mehler1">[16]</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 1698 1703 <span type="species:ncbi:9606">human</span>
###xml 1824 1829 <span type="species:ncbi:9606">human</span>
While at least 40-50% of the human genome is transcribed into RNA, only 1.2% of the genome is translated into protein [1]-[3]. RNAs which do not code for proteins (noncoding RNAs) have been classified into different classes (tRNA, rRNA, snRNA, snoRNA, miRNA, siRNA, piRNA, natural antisense transcripts and long noncoding RNA) based on their size and function. Novel classes of noncoding RNAs have been shown to have a variety of functions which include translational inhibition (miRNA) [4], mRNA degradation (siRNA) [5], and repressing transposition (piRNA) [6], [7]. Also, thousands of protein coding genes have now been shown to have antisense transcripts [8]. Antisense transcript manipulation can in some cases lead to the repression of the sense transcript (discordant regulation) or enhance the stability of the sense transcript (concordant regulation) [8]. However, the exact mechanisms by which antisense transcripts regulate their sense partners are likely diverse and require further studies. Another class of noncoding RNAs is long noncoding RNAs (or "macroRNA") [9], [10] which do not overlap with protein-coding genes and range from 300 nucleotides to over 10 kb in size with an average size of approximately2 kb [9], [11]. Notably, the sequence of noncoding RNAs, in contrast to other noncoding RNAs such as miRNAs and snoRNAs, is often not well conserved even between mammals [9] and can function both in cis (e.g., XIST) [12] and in trans (e.g., HOTAIR) [13]. In contrast to other noncoding RNAs, only a small number of long noncoding RNAs have been functionally characterized. Several studies have now shown that the expression pattern of noncoding RNAs can be altered in several human diseases such as cancers and heart disease [14], [15] suggesting that noncoding RNAs may have a functional relevance to human disease and that they may be considered as potential drug targets [11], [16].
###end p 4
###begin p 5
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Verkerk1">[17]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Oostra1">[19]</xref>
###xml 281 285 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 350 354 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Hinds1">[20]</xref>
###xml 559 563 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Tassone1">[21]</xref>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Oostra2">[22]</xref>
###xml 775 779 775 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1006 1010 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Engstrom1">[23]</xref>
###xml 1132 1136 1132 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1210 1214 1210 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1238 1246 1238 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1263 1267 1263 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 999 1005 <span type="species:ncbi:9606">humans</span>
###xml 1314 1319 <span type="species:ncbi:9606">human</span>
Fragile X syndrome (FXS), the most common cause of inherited mental retardation, is caused by the expansion of CGG trinucleotide repeats in the 5' UTR of the fragile X mental retardation 1 gene (FMR1) [17]-[19]. Normal individuals have a range of 5-50 CGG repeats in the 5' UTR of FMR1 and express FMR1 in a wide range of adult and embryonic tissues [20]. The CGG repeats can expand in the female germ line or shortly after fertilization by an unknown mechanism. Individuals with 55-200 repeats are premutation carriers and generally express higher levels of FMR1 mRNA than normal individuals and may result in a clinical condition termed fragile X tremor and ataxia syndrome (FXTAS) [21], [22]. The expansion of CGG repeats above 200 leads to the repression or silencing of FMR1 and consequently to the absence of the fragile X mental retardation protein (FMRP). We have previously been part of effort to identify and characterize 2,113 bidirectional promoters from 42,887 transcriptional units in humans [23]. In the present manuscript, we report the discovery and functional characterization of a primate-specific noncoding RNA (FMR4) that becomes silenced as a result of the CGG expansion in the 5' UTR of FMR1 in fragile X syndrome. In vitro manipulation of FMR4 indicates it has an antiapoptotic function in human cells.
###end p 5
###begin title 6
Results
###end title 6
###begin title 7
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
Identification and expression analysis of FMR4
###end title 7
###begin p 8
###xml 116 119 116 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Katayama1">[8]</xref>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Engstrom1">[23]</xref>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 441 445 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 523 534 523 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g001">Figure 1A&#8211;B</xref>
###xml 574 578 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 644 648 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 690 698 690 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 814 818 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 902 906 902 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 999 1003 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Hinds1">[20]</xref>
###xml 1005 1009 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1176 1185 1176 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001486.s001">Figure S1</xref>
###xml 1215 1219 1215 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1341 1345 1341 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 943 948 <span type="species:ncbi:9606">human</span>
###xml 1040 1045 <span type="species:ncbi:9606">human</span>
###xml 1245 1250 <span type="species:ncbi:9606">human</span>
Previous work by us and others has shown that bidirectional promoters are relatively common in the mammalian genome [8], [23]. Therefore, using genomic approaches, including rapid amplification of cDNA ends (RACE), regular and real time PCR (RT-PCR), we searched for transcripts upstream of FMR1 that could also be affected by the CGG repeat expansion. Here, we report the identification of a novel 2.4 kb long noncoding RNA, which we named FMR4, that resides upstream and likely shares a bidirectional promoter with FMR1 (Figure 1A-B). Bioinformatic analysis suggests that FMR4 does not have a conventional open reading frame, to confirm that FMR4 is indeed a noncoding RNA we carried out in vitro transcription/translation followed by mass spectrometry analysis; however, no protein was detected suggesting that FMR4 is most likely a noncoding RNA (data not shown). Northern blot analysis shows that FMR1 is expressed in the majority of the human tissues examined consistent with previous reports [20]. FMR4 is expressed in several adult human tissues including brain, liver, placenta, small intestine, colon and spleen but not in the pancreas, testes, ovaries or prostate (Figure S1). Two bands corresponding to FMR4 were observed in several human adult tissues, one possibility is that there is alternative transcription start sites for FMR4, however, when we performed our RACE analysis we used RACE ready cDNA from SH-SY5Y cells and obtained only the longer 2.4 kb transcript.
###end p 8
###begin title 9
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
Identification and sequence analysis of FMR4.
###end title 9
###begin p 10
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 168 172 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 208 209 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
(A) Schematic showing known genes in Xq27.3-28 including the newly identified FMR4. FMR4 is transcribed upstream of FMR1 and in the opposite direction. (B) Sequence of FMR4 obtained by rapid amplification of cDNA ends (RACE).
###end p 10
###begin title 11
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
FMR4 is ubiquitously expressed during human development
###end title 11
###begin p 12
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 324 328 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 403 407 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 488 497 488 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g002">Figure 2A</xref>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Sreeram1">[24]</xref>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 469 474 <span type="species:ncbi:9606">human</span>
###xml 583 591 <span type="species:ncbi:9606">patients</span>
Since FMR4 is expressed in several human adult tissues, we next examined its expression levels in human fetal tissues. Using RT-PCR we measured RNA expression levels of FMR4 in seven different human fetal tissues (12 weeks); the RNA from each tissue was pooled from at least three different embryos (GBiosciences). We found FMR4 to be expressed in all the tissues examined including the brain. Notably, FMR4 is highly expressed in the kidney and heart at that stage of human development (Figure 2A). The high expression of FMR4 in the heart is consistent with a previous report that patients with fragile X syndrome have cardiac defects similar to those seen in other disorders of connective tissue such as Marfan's syndrome and Ehlers-Danlos syndrome [24].
###end p 12
###begin title 13
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
Expression analysis of FMR4.
###end title 13
###begin p 14
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 578 582 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 589 593 589 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 598 602 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 686 690 686 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 695 699 695 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 764 768 764 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 773 777 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 407 412 <span type="species:ncbi:9606">human</span>
###xml 635 640 <span type="species:ncbi:9606">human</span>
(A) RT-PCR analysis of FMR4 and FMR1 in seven different human fetal tissues (week 12), RNA from each tissue was pooled from at least three fetuses (GBiosciences). The RNA expression of FMR1 and FMR4 were normalized to whole embryo (set as 100%). Both transcripts are expressed in all the tissues tested with notably high expression of FMR4 in the kidney and heart. (B) RNA was extracted from six postmortem human adult brains from three different regions, thereafter; cDNA synthesis followed by RT-PCR was performed on all samples to measure the relative quantities of FMR1 and FMR4. Both FMR1 and FMR4 are highly expressed in all the human brain regions tested. (C) RT-PCR analysis of FMR4 and FMR1 in several regions of two monkeys brains. The RNA expression of FMR4 and FMR1 were normalized to the insula (set as 100%).
###end p 14
###begin title 15
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 21 26 <span type="species:ncbi:9606">human</span>
FMR4 is expressed in human and monkey brain
###end title 15
###begin p 16
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 502 511 502 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g002">Figure 2B</xref>
###xml 530 534 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 602 606 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 767 771 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 896 905 896 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g002">Figure 2C</xref>
###xml 923 927 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 217 222 <span type="species:ncbi:9606">human</span>
###xml 610 623 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 974 980 <span type="species:ncbi:9606">humans</span>
To determine whether FMR4 shows differential expression within different regions of the human brain, we examined the RNA concentrations of both FMR1 and FMR4 by Real-Time PCR (RT-PCR) using tissue from six postmortem human brains (from four males and two females aged 61-91 years) and studied three different regions (cerebellum, frontal cortex, and hippocampus). By this quantitative method, RT-PCR, both FMR1 and FMR4 were shown to display robust expression levels in all three brain regions tested (Figure 2B). To determine if FMR4 is also expressed in other primates, we examined the expression of FMR4 in rhesus monkey brain regions using RT-PCR. Total RNA from each brain region was isolated from two monkeys and DNAse treated prior to cDNA synthesis. We found FMR4 to be expressed in all the monkey brain regions tested with high expression in the cerebellum and interior parietal cortex (Figure 2C) confirming that FMR4 is expressed in other primates in addition to humans.
###end p 16
###begin title 17
The CGG expansion affects transcription in both directions of a bidirectional promoter
###end title 17
###begin p 18
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 440 449 440 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g003">Figure 3A</xref>
###xml 696 700 696 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 705 709 705 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 733 737 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 846 850 846 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 946 955 946 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g003">Figure 3B</xref>
###xml 1006 1010 1006 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Tassone2">[25]</xref>
###xml 271 279 <span type="species:ncbi:9606">patients</span>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
###xml 836 844 <span type="species:ncbi:9606">patients</span>
###xml 936 944 <span type="species:ncbi:9606">patients</span>
###xml 1075 1083 <span type="species:ncbi:9606">patients</span>
To determine if the expression of FMR4 is affected by the CGG expansion in the 5' UTR of FMR1 that occurs in FXS and/or FXTAS, we investigated the relative expression of FMR4 and FMR1 by RT-PCR in untransformed leukocytes from four control, four premutation and four FXS patients. We found FMR4 expression, similar to FMR1, to be significantly up-regulated in premutation carriers, and shut down in full mutation (FXS) patients (P<0.0001) (Figure 3A). All the samples tested had a matching control without the reverse transcriptase to account for possible DNA contamination. We also utilized regular PCR (35 cycles), gel electrophoresis and ethidium bromide staining to examine the expression of FMR4 and FMR1 from the same samples. FMR4 was detectable in both the normal and premutation carriers but not in the full mutation fragile X patients. FMR1 was detectable in the normal, premutation carriers and one out of the four fragile X patients (Figure 3B); this is not surprising since variable levels of FMR1 mRNA have been previously shown to be present in some fragile X patients [25].
###end p 18
###begin title 19
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
FMR4 is silenced in fragile X syndrome.
###end title 19
###begin p 20
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 634 638 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
###xml 612 620 <span type="species:ncbi:9606">patients</span>
###xml 712 720 <span type="species:ncbi:9606">patients</span>
(A) RNA from four normal, four premutation and four full mutation FXS patients isolated from untransformed leucocytes (kindly provided by Flora Tassone and Paul Hagerman, UC Davis) was reverse transcribed using random hexamers. Quantitative RT-PCR analysis revealed that FMR4, similar to FMR1, is up-regulated in pre-mutation carriers and shut down in full mutation fragile X patients (P<0.0001). (B) RNA from untransformed leucocytes were reversed transcribed and the cDNA was used for PCR analysis. FMR4 is expressed in normal and premutation carriers but no bands were observed in the full mutation fragile X patients (35 cycles). FMR1 bands were observed in normal, premutation, and one of the full mutation patients (35 cycles). To account for any possible DNA contamination, no reverse transcriptase control for all samples were used in the PCR (lanes next to bands are all negative indicating no DNA contamination was present). Error bars: s.d.
###end p 20
###begin title 21
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
FMR4 is a product of RNA polymerase II and has a similar half-life to FMR1
###end title 21
###begin p 22
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 147 151 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Prasanth1">[26]</xref>
###xml 334 339 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actin</italic>
###xml 375 378 363 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 484 489 472 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actin</italic>
###xml 491 494 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 496 500 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 506 510 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 524 527 512 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 655 660 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actin</italic>
###xml 662 666 646 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 671 675 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 768 772 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 800 804 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 806 814 790 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g004">Figure 4</xref>
To measure the relative half-lives of FMR1 and FMR4 we treated HEK-293T cells with 50 microM of alpha-amanitin (an inhibitor of RNA polymerase II) [26] and RNA was isolated at 0, 6, 12 and 24 hours post treatment (six repeats each). All treated samples had a matching control which did not receive alpha-amanitin (untreated samples). Actin was used as a positive control and 18S rRNA was used as a negative control (a product of RNA polymerase I). By RT-PCR we measured the levels of Actin, 18S, FMR1, and FMR4. As expected 18S rRNA levels did not change at any of the time points tested since alpha-amanitin does not affect RNA polymerase I. By contrast Actin, FMR1 and FMR4 were all affected since they are all products of RNA polymerase II. The data indicates that FMR4 has a similar half-life to FMR1 (Figure 4).
###end p 22
###begin title 23
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
FMR4 has a similar half-life to FMR1.
###end title 23
###begin p 24
###xml 93 97 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 102 106 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 177 181 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 186 190 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 260 264 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
HEK-293T cells were treated with alpha-amanitin (blocks RNA polymerase II) and the levels of FMR4 and FMR1 were measured by RT-PCR at 0, 6, 12 and 24 hours post treatment. Both FMR4 and FMR1 have similar half-lives. These experiments also further confirm that FMR4 is a product of RNA polymerase II.
###end p 24
###begin title 25
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
No evidence of direct cross-regulation between FMR1 and FMR4
###end title 25
###begin p 26
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Wahlestedt1">[11]</xref>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Scacheri1">[27]</xref>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 382 391 382 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g002">Figure 2A</xref>
###xml 433 441 433 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 458 462 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 526 530 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 598 602 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 697 701 697 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 764 771 764 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001486-t001">Table 1</xref>
###xml 1016 1020 1016 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1042 1046 1042 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1055 1064 1055 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g005">Figure 5A</xref>
###xml 1116 1120 1116 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1153 1160 1153 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 1209 1213 1209 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1285 1289 1285 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1291 1300 1291 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g005">Figure 5B</xref>
###xml 1311 1315 1311 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1358 1362 1358 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1464 1468 1464 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1591 1595 1591 1595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1615 1619 1615 1619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1661 1670 1661 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g005">Figure 5C</xref>
###xml 1688 1692 1688 1692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1754 1758 1754 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1808 1812 1808 1812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1956 1960 1956 1960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 2009 2013 2009 2013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 2057 2061 2057 2061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 2067 2076 2067 2076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g005">Figure 5D</xref>
###xml 2156 2160 2156 2160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 2165 2169 2165 2169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 358 363 <span type="species:ncbi:9606">human</span>
###xml 1723 1726 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To determine whether FMR1 and FMR4 are functionally linked, we tested three different siRNAs against FMR1 and identified three different newly designed siRNAs against FMR4. It is important to utilize multiple efficacious siRNAs to any given target in order to avoid the possibility of off-target phenomena [11], [27]. Also, since FMR4 is highly expressed in human embryonic kidney (Figure 2A), we decided to use HEK-293T cells as an in vitro system to study FMR4 regulation and function. First, we tested three siRNAs against FMR1 by transfecting HEK-293T cells with 20 nM (final concentration) of FMR1 siRNAs (six repeats each). Two out of the three siRNAs tested were effective in knocking down FMR1 by 80% as early as 48 hours post transfection (siRNA B and C, Table 1). This level of knockdown was also observed at 72 hours post transfection and in repeated transfection experiments (144 hours total, two transfections at 0 hour and 72 hours post first transfection). However, in all cases the concentrations of FMR4 were not affected by FMR1 siRNAs (Figure 5A). We designed and tested nine different siRNAs for FMR4, three siRNAs (C, G, and H, see methods for sequences) caused a significant decrease in FMR4 at 48 and 72 hours post transfection, but did not affect the levels of FMR1 (Figure 5B). We used FMR4 siRNA C which caused the highest level of FMR4 knockdown among the siRNAs tested for a time course experiment. HEK-293T cells were transfected with FMR4 siRNA C and RNA was collected at 24, 48, 72 and 144 hours post transfection. This siRNA caused a significant knockdown of FMR4 but did not affect FMR1 levels at any of the time points tested (Figure 5C). We next cloned FMR4 into a pcDNA3.1 vector with a CMV promoter and overexpressed FMR4 in HEK-293T cells, a pcDNA3.1 vector without the FMR4 insert was used as a control. At 72 hours post transfection, RNA was isolated, reversed transcribed and used for RT-PCR analysis. As expected, FMR4 overexpression led to a substantial increase in FMR4 RNA levels, but did not have any effect on FMR1 RNA (Figure 5D). Collectively, these experiments suggest that the non-overlapping transcripts FMR1 and FMR4 do not regulate each other.
###end p 26
###begin title 27
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4.</italic>
No direct cross-regulation between FMR1 and FMR4.
###end title 27
###begin p 28
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 562 566 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 657 661 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 908 912 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 941 945 941 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 608 611 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(A) We used three distinct siRNAs against FMR1 to transfect HEK-293T cells. Two out of the three siRNAs resulted in a significant knockdown of FMR1 (80%), but did not affect FMR4 RNA levels. (B) We used three distinct siRNAs against FMR4 to transfect HEK-293T cells. All three siRNAs resulted in a significant knockdown of FMR4 but did not affect FMR1 RNA levels. (C) Significant knockdown of FMR4 via siRNA C did not result in a change in FMR1 RNA levels at any of the time points tested (24, 48, 72, or 144 hours post transfection). (D) The entire sequence of FMR4 was cloned into a pcDNA3.1 vector with a CMV promoter. The pcDNA3.1 vector containing the FMR4 sequence and the original pcDNA3.1 (without the FMR4 insert) were transfected in HEK-293T cells. At 72 hours post transfection, RNA was isolated and reversed transcribed and used for RT-PCR analysis. There is a highly significant increase in the FMR4 RNA levels but no effect on FMR1 RNA. Error bars: s.d.
###end p 28
###begin title 29
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
Sequences of FMR1 and FMR4 siRNAs.
###end title 29
###begin title 30
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
FMR4 affects cell proliferation in human cells
###end title 30
###begin p 31
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 181 188 181 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 272 280 272 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1, or</italic>
###xml 645 649 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 789 798 789 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g006">Figure 6A</xref>
###xml 831 835 831 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 993 997 993 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1109 1118 1109 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g006">Figure 6B</xref>
###xml 1152 1156 1152 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1246 1255 1246 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g006">Figure 6B</xref>
###xml 1399 1403 1399 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1460 1469 1460 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g007">Figure 7A</xref>
###xml 1510 1514 1510 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1551 1555 1551 1555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1645 1649 1645 1649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1709 1713 1709 1713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1836 1847 1836 1847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g006">Figure 6C&#8211;D</xref>
###xml 1872 1876 1872 1876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1933 1942 1933 1942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g007">Figure 7B</xref>
###xml 883 888 <span type="species:ncbi:9606">human</span>
###xml 1305 1310 <span type="species:ncbi:10090">mouse</span>
###xml 1443 1448 <span type="species:ncbi:10090">mouse</span>
###xml 1880 1885 <span type="species:ncbi:10090">mouse</span>
To uncover a possible function for FMR4, we examined the effects of three distinct and efficacious siRNAs against FMR4 on cell proliferation using a luciferase reporter system (see methods). HEK-293T cells were transfected with either siRNAs targeting FMR4 (C, G, and H), FMR1, or a control siRNA. All cells were simultaneously co-transfected with a pGL3 (luciferase) vector. At 72 hours post transfection, luciferase activity, which is a marker of cell proliferation, was measured using an Analyst GT Multimode Reader (Molecular Devices) and all data points were plotted as a percentage of control siRNA treated cells. All three siRNAs against FMR4, but not the siRNA against FMR1, resulted in significant decreases in cell proliferation in comparison to the control siRNA treated cells (Figure 6A). To determine if the effect of FMR4 on cell proliferation is reproducible in other human cell lines we carried out a similar experiment using HeLa cells and found that all three siRNAs against FMR4 also resulted in highly significant decreases in cell proliferation in comparison to control siRNA (P<0.0001) (Figure 6B). In contrast to HEK-293T cells, FMR1 siRNA resulted in a marginally significant decrease in cell proliferation in HeLa cells (Figure 6B). We also carried out a similar experiment using mouse N2A neuroblastoma cells as a negative control experiment and as expected siRNAs against FMR4 had no effect on cell proliferation in mouse N2A cells (Figure 7A). To determine if the overexpression of FMR4 have an opposite effect compared to FMR4 siRNAs knockdown on cell proliferation, we next transfected HEK-293T and HeLa cells with FMR4 overexpression vector. We found that the overexpression of FMR4 in both cell lines resulted in an increase in cell proliferation compared to the control vector treated cells (P<0.0001) (Figure 6C-D). The overexpression of FMR4 in mouse N2A cells had no effect on cell proliferation (Figure 7B).
###end p 31
###begin title 32
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 30 35 <span type="species:ncbi:9606">human</span>
FMR4 affects proliferation in human cells.
###end title 32
###begin p 33
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 651 655 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
(A) Cell proliferation assay showing that the knockdown of FMR4 via three distinct siRNAs in HEK-293T cells, but not knockdown of FMR1, resulted in decrease in cell proliferation in comparison to cells which are treated with a negative control siRNA. Cell proliferation was measured based on luciferase activity in these cells at 72 hours post siRNA transfection. (B) Cell proliferation assay showing that the knockdown of FMR4 via three distinct siRNAs in HeLa cells resulted in decrease in cell proliferation in comparison to cells which are treated with a negative control siRNA (P<0.0001). (C-D) In both HEK-293T and HeLa cells, overexpression of FMR4 resulted in an increase in cell proliferation in comparison to cells treated with a control vector. Error bars: s.d.
###end p 33
###begin title 34
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
The effect of FMR4 on cell proliferation is not observed in non-primates.
###end title 34
###begin p 35
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 168 172 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 635 639 635 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 928 932 928 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 280 285 <span type="species:ncbi:10090">Mouse</span>
###xml 544 549 <span type="species:ncbi:10090">Mouse</span>
###xml 845 850 <span type="species:ncbi:9606">human</span>
###xml 941 946 <span type="species:ncbi:10090">mouse</span>
Since FMR4 is a primate-specific transcript we examined its effect on cell proliferation in non-primates using mouse N2A cells. We examined both the siRNA knockdown of FMR4 (as a negative control experiment) and the over-expression of FMR4 on cell proliferation in N2A cells. (A) Mouse N2A cells were transfected with FMR4 siRNA C and a control siRNA. Simultaneously, cells were transfected with pGL3 (luciferase) vector. At 72 hours post transfection luciferase activity was measured and data are graphed as a percentage of control siRNA. (B) Mouse N2A cells were transfected with FMR4 over-expression vector and a control vector (no FMR4 insert). Simultaneously, cells were transfected with pGL3 (luciferase) vector. At 72 hours post transfection luciferase activity was measured and data are graphed as a percentage of control vector. Unlike human cells which show an increase in cell proliferation when transfected with the FMR4 vector, mouse N2A cells did not show any change in proliferation.
###end p 35
###begin title 36
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
FMR4 has antiapoptotic properties
###end title 36
###begin p 37
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 229 233 229 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 351 358 351 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 399 403 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 562 571 562 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g008">Figure 8A</xref>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 773 777 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 885 889 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 936 947 936 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g008">Figure 8B&#8211;C</xref>
###xml 637 642 <span type="species:ncbi:9606">human</span>
###xml 923 928 <span type="species:ncbi:9606">human</span>
To further characterize the manner in which FMR4 affects cell proliferation, we knocked down FMR4 using two different siRNAs (four repeats each), and we used a control negative siRNA (four repeats also) to examine the effects of FMR4 on the cell cycle in HEK-293T cells. At 72 hours post transfection, we performed propidium iodide FACS analysis (see methods) and found that the siRNAs knockdown of FMR4 resulted in an increase in the number of cells in the Sub-G1 phase and a modest but significant decrease in the number of cells in S phase of the cell cycle (Figure 8A). This suggested that FMR4 may have an antiapoptotic function in human cells; therefore, we next performed a fluorescent TUNEL assay and found a significant increase in apoptosis in cells treated with FMR4 siRNA (72 hours post transfection) compared to cells treated with a control siRNA, further indicating that FMR4 has an antiapoptotic function in human cells (Figure 8B-C).
###end p 37
###begin title 38
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
FMR4 has an antiapoptotic function in human cells.
###end title 38
###begin p 39
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 557 561 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 786 790 786 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
(A) Cell cycle analysis of control cells (red) and cells treated with two different siRNAs against FMR4 (green and blue) shows that knockdown of FMR4 resulted in a highly significant increase in the number of cells in Sub-G1 and a modest but significant decrease in the number of cells in the S phase suggesting a possible role in apoptosis. (B) Microscope images of cells (DAPI stained) treated with a control siRNA and cells treated with FMR4 siRNA for 72 hours prior to a TUNEL assay. A significant number of cells are undergoing apoptosis (FITC) in the FMR4 siRNA treated cells in comparison to the control siRNA treated cells. (C) Quantification of cells following a TUNEL assay indicated that there is at least a two-fold change in the number of cells undergoing apoptosis in the FMR4 siRNA treated cells in comparison to the control siRNA treated cells. Error bars: s.d.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 154 158 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 463 473 463 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1, FMR4</italic>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 591 595 591 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 804 808 804 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 885 889 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1078 1082 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Sreeram1">[24]</xref>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Waldstein1">[28]</xref>
###xml 1122 1126 1122 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1142 1151 1142 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001486-g002">Figure 2A</xref>
###xml 1261 1266 1261 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4.</italic>
###xml 269 274 <span type="species:ncbi:9606">human</span>
###xml 326 331 <span type="species:ncbi:9606">human</span>
###xml 336 349 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 772 777 <span type="species:ncbi:9606">human</span>
###xml 961 969 <span type="species:ncbi:9606">patients</span>
###xml 1203 1208 <span type="species:ncbi:9606">human</span>
In the present manuscript we report the discovery of a 2.4 kb noncoding RNA (FMR4) which is transcribed upstream of FMR1. There is no overlap between the FMR1 and FMR4 transcripts, and therefore, FMR4 is not a natural antisense transcript to FMR1. FMR4 is expressed in human adult and fetal tissues, and in several regions of human and rhesus monkey adult brain but at varying concentrations. Despite the likelihood that FMR4 shares a bidirectional promoter with FMR1, FMR4 is not expressed in the adult testes, ovary and prostate where FMR1 is highly expressed. It is possible however that FMR4 is expressed in these tissues during embryonic and/or fetal development as the RNAs used in our experiments from these tissues (testes, ovary, and prostate) were obtained from human adults. Notably, we found FMR4 to be highly expressed in fetal heart and kidney. The cardiac expression of FMR4 may possibly be of functional relevance considering the fact that many patients with fragile X syndrome exhibit heart defects such as dilation of the aortic root and mitral valve prolapse [24], [28]. Moreover the high expression of FMR4 in the kidney (Figure 2A) appears consistent with our observations that the human embryonic kidney cell line, HEK-293, also expresses FMR4.
###end p 41
###begin p 42
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 172 181 172 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001486.s002">Figure S2</xref>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 459 463 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 721 725 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 772 776 760 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1003 1006 991 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g</italic>
###xml 1094 1097 1082 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Pang1">[9]</xref>
###xml 1149 1153 1137 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xist</italic>
###xml 1172 1176 1160 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Chureau1">[29]</xref>
###xml 1241 1245 1229 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Nesterova1">[30]</xref>
###xml 1296 1300 1284 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XIST</italic>
###xml 1327 1331 1315 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Davidow1">[31]</xref>
###xml 1333 1337 1321 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Hore1">[32]</xref>
###xml 1437 1441 1425 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XIST</italic>
###xml 1456 1460 1444 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Okamoto1">[33]</xref>
###xml 1571 1575 1559 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XIST</italic>
###xml 116 129 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 165 170 <span type="species:ncbi:10090">mouse</span>
###xml 247 252 <span type="species:ncbi:10090">mouse</span>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
###xml 453 458 <span type="species:ncbi:9606">human</span>
###xml 603 608 <span type="species:ncbi:10090">mouse</span>
###xml 715 720 <span type="species:ncbi:9606">human</span>
###xml 1133 1138 <span type="species:ncbi:9606">human</span>
###xml 1143 1148 <span type="species:ncbi:10090">mouse</span>
Bioinformatics analysis shows that the genomic sequence encompassing FMR4 is conserved in other primates (chimp and rhesus monkey) with only partial homology to the mouse (Figure S2). Interestingly, however, there is an apparent transcript in the mouse X chromosome that is on the minus strand that starts approximately 100 bp upstream of the mouse Fmr1 gene. This transcript (NCBI accession number AK148387) does not have significant homology with the human FMR4 transcript (approximately3% nucleotide identity by ClustalW using default analysis parameters for nucleotide sequences). Furthermore, this mouse transcript appears to be highly spliced and contains 4 exons, which is an additional distinction from the human FMR4 transcript. However, we can not rule out that FMR4 and AK148387, despite their genomic differences, still perform a similar function. The majority of noncoding RNAs identified to date seem to be poorly conserved even among mammals; this is in contrast to other noncoding RNAs (e.g., microRNAs and snoRNAs) which show a high level of conservation among diverse species [9]. It is worth noting that while the human and mouse Xist show 66% homology [29]; however, there seems to be rapid evolution of unique sequences [30]. Also, several attempts to find an orthologue for XIST in marsupials have failed [31], [32] despite the fact that imprinted X inactivation still occurs in marsupials, a process that requires XIST in eutharians [33] suggesting the possibility that a non-conserved noncoding RNA in marsupials may perform a similar function to XIST.
###end p 42
###begin p 43
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 467 471 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 495 499 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXC</italic>
###xml 507 513 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOTAIR</italic>
###xml 515 519 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Rinn1">[13]</xref>
###xml 525 531 525 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOTAIR</italic>
###xml 570 578 570 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXD</italic>
###xml 698 702 698 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXD</italic>
###xml 709 713 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Rinn1">[13]</xref>
###xml 745 749 745 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 781 789 781 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
We found that FMR4 regulates human cell proliferation in vitro; knockdown of FMR4 resulted in alterations in the cell cycle and apoptosis while the overexpression of FMR4 leads to an increase in cell proliferation. While the involvement of poorly studied protein coding gene(s) within the FMR1 genomic locus cannot be excluded at this time, our results suggest that the FMR4 function involves a noncoding mechanism. Recently, a long noncoding RNA, similar in size to FMR4, was identified in the HOXC locus (HOTAIR) [13]. The HOTAIR noncoding RNA represses transcription in trans across 40 kb of the HOXD locus by altering the chromatin modifications through enhancement of the PCR2 activity at the HOXD locus [13]. It is therefore possible that FMR4 may also target a set of genes in trans resulting in its antiapoptotic properties. In conclusion, our findings should add further evidence that novel nonconserved noncoding RNAs may be functional and that they do not simply represent "transcriptional noise".
###end p 43
###begin p 44
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Ladd1">[34]</xref>
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ASFMR1</italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 297 303 297 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ASFMR1</italic>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 386 392 386 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ASFMR1</italic>
###xml 472 475 472 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001486-Carninci1">[1]</xref>
###xml 604 610 604 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ASFMR1</italic>
###xml 731 735 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 844 848 844 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 895 901 895 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ASFMR1</italic>
###xml 950 954 950 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1018 1022 1018 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1212 1218 1212 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ASFMR1</italic>
###xml 1506 1512 1506 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1567 1573 1567 1573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ASFMR1</italic>
###xml 1581 1585 1581 1585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 1639 1645 1639 1645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1689 1693 1689 1693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1865 1869 1865 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1900 1904 1900 1904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 234 242 <span type="species:ncbi:9606">patients</span>
###xml 1916 1921 <span type="species:ncbi:9606">human</span>
While our manuscript was under review, Ladd et al. published on an antisense transcript that spans the CGG repeats in the 5' UTR of FMR1[34]. This transcript, ASFMR1, is up-regulated in premutation carriers and shut down in fragile X patients similar to FMR1 and FMR4. Also, one splice variant of ASFMR1 overlaps with FMR4, therefore it is possible that FMR4 is nested in the 3' UTR of ASFMR1, a phenomenon seems to be prevalent in many genes throughout mammalian genomes [1] or another possibility is that these two transcripts may also have contiguous isoforms which is another intriguing possibility. ASFMR1 appears to be highly spliced and has multiple transcription start sites. One transcription start site is in intron 2 of FMR1 at position +10243. This transcription start site was identified by utilizing a 5' RACE primer in exon 1 of FMR1. Also, multiple transcription start sites for ASFMR1 were also identified in -99 to -208 upstream of FMR1 by designing 5' RACE primers in the -1000 position relative to FMR1. From these experiments it is not clear if the transcript which starts in the +10243 is the same transcript as the one that initiates in the -99 to -208. If these two transcripts were both ASFMR1, the authors should have been able to clone the longer transcript which initiates at +10243 using the 5' RACE primers which they used to identify the multiple transcription start sites in the -99 to -208 positions. Therefore, another possibility is that one of the transcripts that Ladd et al. cloned and identified as an alternative transcript to ASFMR1 is the FMR4 transcript. In essence, our findings along with Ladd et al. suggest a complex transcription within the FMR1 locus than previously thought and should provide an incentive for further studies to determine the exact nature of all the transcripts, and their function, throughout the FMR1 region and their relevance to FMR1-associated human disorders (fragile X syndrome and FXTAS).
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
Rapid amplification of cDNA ends (RACE)
###end title 46
###begin p 47
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 285 289 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 306 310 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 323 343 319 339 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGAGTTGAGGAAAGGCGAGT</named-content>
###xml 345 349 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 362 382 358 378 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTGAGATCCCGACTCAATCC</named-content>
The genomic sequence for FMR1 locus was obtained from the UCSC website (). RACE-ready cDNA (0.5 ng/microl) from SH-SY5Y cells for 5' and 3' RACE was custom made by Ambion (Austin, TX). RACE primers were designed using Primer3 software and the name and sequence of the RACE primers for FMR4 is listed here: FMR4 5' outer 1: TGAGTTGAGGAAAGGCGAGT; FMR4 5' inner 1: TTGAGATCCCGACTCAATCC. We carried out two rounds of PCR using the outer and inner primers sequentially. First PCR was carried out using 10 microl of RACE-ready cDNA and the second PCR was carried out using 2 microl of the first PCR product. PCR conditions were as follow: 94 C for 5 minutes, (94 C for 30 seconds, 59 C for 30 seconds, 72 C for 2 minutes) for 35 cycles, 72 C for 10 minutes. Both first and second PCR products were ran on a 2% agarose gel and bands of interest were cut, purified, cloned into pGEM T-easy vector (Promega, Madison, WI) before sequencing (UC Davis Sequencing Core Facility).
###end p 47
###begin title 48
RNA Extraction and cDNA synthesis
###end title 48
###begin p 49
Total RNA was extracted using Quiagen RNeasy mini kit (catalogue # 74106). RNA concentrations were measured using The NanoDrop(R) ND-1000 UV-Vis Spectrophotometer. Equal amounts of RNA were reversed transcribed using TaqMan reverse transcription reagents (part # N808-0234) according to the manufacturer's protocol.
###end p 49
###begin title 50
Real-Time PCR
###end title 50
###begin p 51
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 21 41 21 41 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACACCCTGTGCCCTTTAAGG</named-content>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 64 86 64 86 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCAAAGCTGGGTCTGAGGAAAG</named-content>
###xml 106 123 106 123 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCGGGATCTCAAAATGT</named-content>
FMR4 forward primer: ACACCCTGTGCCCTTTAAGG, FMR4 reverse primer: TCAAAGCTGGGTCTGAGGAAAG, Reporter (probe): TCGGGATCTCAAAATGT. Real-Time PCR (RT-PCR) was carried out with the GeneAmp 7900 (Applied Biosystems, Foster City, CA). The PCR reactions contained 20-40 ng cDNA, Universal Mastermix (Applied Biosystems, Foster City, CA), 300 nM of forward and reverse primers, and 200 nM of probe in a final reaction volume of 15 microl. The primers and probe were designed using File-Builder software (Applied Biosystems, Foster City, CA). The PCR conditions were as follows: 50 C for 2 min then 95 C for 10 min then 40 cycles of 95 C for 15 s and 60 C for 1 min. The results are based on cycle threshold (Ct) values. Differences between the Ct values for experimental and reference genes (18srRNA) were calculated as DeltaDeltaCt.
###end p 51
###begin title 52
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro transcription and translation
###end title 52
###begin p 53
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 102 110 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 239 247 239 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 149 152 <span type="species:ncbi:9685">Cat</span>
1 ug of pcDNA3.1 containing the FMR4 sequence (or without the sequence as a control) was utilized for in vitro transcription using a MAXIscript kit (Cat # AM1200, Ambion, Austin, TX) according to manufacturer's instructions. Subsequently, in vitro translation was carried out using the Retic Lysate IVT kit (Ambion, Austin, TX) according to manufacturer's instructions, except that Fluorotect Green-Lys (Promega, Madison, WI) was included in the translation mixture according to manufacturer's suggestions. Fluorotect Green-Lys, is a BIODPY labeled lysine that allows the addition of a fluorescent amino acid to any newly synthesized peptide (unlabeled lysine is also included in the reaction mixture) allowing for fluorescent detection of such peptides.
###end p 53
###begin title 54
Northern blot analysis
###end title 54
###begin p 55
###xml 391 393 387 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 76 79 <span type="species:ncbi:9685">cat</span>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 339 342 <span type="species:ncbi:9685">cat</span>
We purchased a human ready-to-hybridize northern blot membrane from Ambion (cat# 3141) which has 2 microg of poly(A) RNA per lane isolated from human brain, liver, placenta, small intestine, colon, pancreas, spleen, prostate, testes, and ovary. The membrane was initially incubated with 15 ml of pre-warmed hybridization solution (Ambion, cat#8670) for 1 hour at 65 C. Northern blot probes (32P) were generated using Amersham rediprime II random prime labeling system (RPN1633) according to the manufacturer's protocol (GE Healthcare, Piscataway, NJ). We added 14 microl of the probe per 5 ml of hybridization buffer (42 microl total) to the membrane for overnight incubation at 42 C. Two low-stringency and two high-stringency washes were performed for 15 minutes each prior to exposing the membrane for phosphor imager.
###end p 55
###begin title 56
Cell culture, siRNA transfection and RNA isolation
###end title 56
###begin p 57
###xml 566 570 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 575 579 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 601 608 601 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001486-t001">table 1</xref>
HEK-293T and N2A cells were cultured in MEM plus 10% FBS. Cells in the logarithmic growth phase were transfected with 20 nM of siRNA using 0.2% Lipofectamine 2000 according to manufacturer's instructions (Invitrogen, Carlsbad, CA). Cells were incubated for 72 h or transfected a second time for an additional 72 hours prior to RNA isolation. RNA was isolated using QIAGEN RNeasy mini-kit (QIAGEN, Valencia, CA). All samples were treated with RNAse-free DNase (QIAGEN, Valencia, CA, #79254) for 20 minutes as described in the manufacturer's protocol. The sequence of FMR1 and FMR4 siRNAs are listed in table 1.
###end p 57
###begin title 58
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
FMR4 over-expression
###end title 58
###begin p 59
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 177 182 <span type="species:ncbi:9606">human</span>
###xml 187 192 <span type="species:ncbi:10090">mouse</span>
The entire cDNA sequence of FMR4 was cloned into pcDNA3.1 vector. The vector was sequenced to verify the insertion of the FMR4 sequence. The vector was transfected into several human and mouse cell lines using standard procedures.
###end p 59
###begin title 60
Stability and alpha-amanitin treatment
###end title 60
###begin p 61
HEK-293T cells were cultured in 6 well plates. Twenty-four h later, cells were treated with 50 microg/ml of alpha-amanitin (Sigma, St. Louis, MO). Cells were harvested for RNA isolation and RT-PCR at 0, 6, 12, and 24 hours post treatment. Three independent samples were taken for each data point and all samples had untreated matching samples for RNA purification and data analysis.
###end p 61
###begin title 62
Cell proliferation assay
###end title 62
###begin p 63
###xml 71 75 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Using Multidrop 384Titan, 50 ng of PGL3 vector (luciferase vector with SV40 promoter), 20 nM of siRNA and transfection reagents (Lipofectamine 2000 0.2% and OptiMEM, Invitrogen, CA) were plated in 96 well plates. Equal number of cells (20,000 per well) were added to each well and incubated at 37degreesC for 72 hours. Bright-Glo luciferase reagent (Promega, Madison, WI) was added to each well and incubated at room temperature for 5 minutes. Luciferase activity, as a marker of cell proliferation, was measured by Analyst GT Multimode Reader (Molecular Devices, Sunnyvale, CA) and plotted against control siRNA.
###end p 63
###begin title 64
Cell cycle analysis
###end title 64
###begin p 65
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
We knocked down FMR4 using two different siRNAs (4 repeats each), and we used a control negative siRNA (4 repeats also) to examine the effects of FMR4 on the cell cycle. At 72 hours post transfection, we prepared the cells for flow cytometry as follow: cells were washed with PBS, trypsynized and centrifuged at 1,000 rpm for 10 minutes. Then the cells were washed again with PBS before being fixed with 70% ethanol at -20C overnight. The next day the cells were centrifuged, washed with PBS and re-suspended in 38 mM sodium citrate, 69 microM propidium iodide and 19 microg/ml RNAse A for flow cytometry analysis. Results were analyzed using FlowJo analysis software.
###end p 65
###begin title 66
TUNEL assay
###end title 66
###begin p 67
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 280 281 280 281 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 295 296 295 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</bold>
###xml 299 300 299 300 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</bold>
###xml 304 305 304 305 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</bold>
###xml 308 309 308 309 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</bold>
HEK-293T cells were plated on cover slips prior to treatment with a control siRNA or siRNAs against FMR4. At 72 hours post transfection, the cells were fixed with 4% paraformaldehyde (pH 7.4) for 15 min at room temperature, followed by permeabilization with 0.1% triton-X in PBS. TdT- mediated dUTP nick end labeling (TUNEL) reaction mixture was added to the cells and incubated at 37C for 1 hour (Roche, Indianapolis, IN). The cells were then stained with DAPI and images were captured using a confocal microscope.
###end p 67
###begin title 68
Supporting Information
###end title 68
###begin p 69
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 122 127 <span type="species:ncbi:9606">human</span>
Northern blot analysis of FMR1 and FMR4 in human adult tissues. FMR1 and FMR4 are co-expressed in some but not all of the human adult tissues examined.
###end p 69
###begin p 70
(0.38 MB TIF)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
Bioinformatic analysis of the genomic DNA sequence encompassing FMR4.
###end p 72
###begin p 73
(0.17 MB DOC)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
###xml 360 373 <span type="species:ncbi:9544">rhesus monkey</span>
We are grateful to Drs. Flora Tassone and Paul Hagerman (UC Davis) for helpful discussions and their kind gift of total RNA from untransformed leukocytes from normal, premutation and full mutation individuals. We thank Drs. Nagi Ayad and Charles Weissmann (Scripps) for critically reading the manuscript. Diane Stephenson (Pfizer) kindly provided tissues from rhesus monkey brain regions.
###end p 75
###begin title 76
References
###end title 76
###begin article-title 77
The transcriptional landscape of the mammalian genome.
###end article-title 77
###begin article-title 78
###xml 27 32 <span type="species:ncbi:9606">human</span>
Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution.
###end article-title 78
###begin article-title 79
###xml 64 69 <span type="species:ncbi:9606">human</span>
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.
###end article-title 79
###begin article-title 80
MicroRNAs: genomics, biogenesis, mechanism, and function.
###end article-title 80
###begin article-title 81
###xml 67 89 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.
###end article-title 81
###begin article-title 82
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline.
###end article-title 82
###begin article-title 83
###xml 80 89 <span type="species:ncbi:7955">Zebrafish</span>
A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in Zebrafish.
###end article-title 83
###begin article-title 84
Antisense transcription in the mammalian transcriptome.
###end article-title 84
###begin article-title 85
Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function.
###end article-title 85
###begin article-title 86
Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs.
###end article-title 86
###begin article-title 87
Natural antisense and noncoding RNA transcripts as potential drug targets.
###end article-title 87
###begin article-title 88
X chromosome inactivation: theme and variations.
###end article-title 88
###begin article-title 89
###xml 65 70 <span type="species:ncbi:9606">human</span>
Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs.
###end article-title 89
###begin article-title 90
###xml 38 43 <span type="species:ncbi:9606">human</span>
A microRNA polycistron as a potential human oncogene.
###end article-title 90
###begin article-title 91
###xml 31 36 <span type="species:ncbi:9606">human</span>
Altered microRNA expression in human heart disease.
###end article-title 91
###begin article-title 92
Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease.
###end article-title 92
###begin article-title 93
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.
###end article-title 93
###begin article-title 94
Transcription, translation and fragile X syndrome.
###end article-title 94
###begin article-title 95
The fragile X gene and its function.
###end article-title 95
###begin article-title 96
Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome.
###end article-title 96
###begin article-title 97
Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.
###end article-title 97
###begin article-title 98
A fragile balance: FMR1 expression levels.
###end article-title 98
###begin article-title 99
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Complex Loci in human and mouse genomes.
###end article-title 99
###begin article-title 100
Cardiac abnormalities in the fragile X syndrome.
###end article-title 100
###begin article-title 101
A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA.
###end article-title 101
###begin article-title 102
Regulating gene expression through RNA nuclear retention.
###end article-title 102
###begin article-title 103
Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells.
###end article-title 103
###begin article-title 104
###xml 58 61 <span type="species:ncbi:9606">boy</span>
Aortic hypoplasia and cardiac valvular abnormalities in a boy with fragile X syndrome.
###end article-title 104
###begin article-title 105
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 87 93 <span type="species:ncbi:9913">bovine</span>
Comparative sequence analysis of the X-inactivation center region in mouse, human, and bovine.
###end article-title 105
###begin article-title 106
Characterization of the genomic Xist locus in rodents reveals conservation of overall gene structure and tandem repeats but rapid evolution of unique sequence.
###end article-title 106
###begin article-title 107
The search for a marsupial XIC reveals a break with vertebrate synteny.
###end article-title 107
###begin article-title 108
The region homologous to the X-chromosome inactivation centre has been disrupted in marsupial and monotreme mammals.
###end article-title 108
###begin article-title 109
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Epigenetic dynamics of imprinted X inactivation during early mouse development.
###end article-title 109
###begin article-title 110
An Antisense Transcript Spanning the CGG Repeat Region of FMR1 is Upregulated in Premutation Carriers but Silenced in Full Mutation Individuals.
###end article-title 110
###begin p 111
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 111
###begin p 112
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Conquer Fragile X Foundation and the Scripps Research Institute have provided funding.
###end p 112

